Search results
Novavax (NVAX) Gets Nod for COVID-19 Booster Jab in South Korea
Zacks via Yahoo Finance· 1 year agoNovavax NVAX announced that its partner SK bioscience received expanded manufacturing and marketing...
Novavax to sell 7% stake to South Korea's SK Bioscience
Reuters via AOL· 10 months ago(Reuters) -SK Bioscience is taking a roughly 7% stake in Novavax in lieu of some payment owed to the South Korean biotech company, giving the cash-strapped COVID-19 vaccine maker some breathing ...
Novavax (NVAX) Q2 Earnings Beat, Stock Down 4% on '23 Sales Cut
Zacks via Yahoo Finance· 10 months agoNovavax (NVAX) reports better-than-expected Q2 earnings results, as earnings and revenues beat...
Q4 2023 Arcus Biosciences Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants Pia Eaves; Vice President, Investor Relations; Arcus Biosciences Inc Terry Rosen; Chief Executive Officer; Arcus Biosciences Inc Jennifer Jarrett; Chief Operating Officer; Arcus ...
Why Novavax Stock Is Skyrocketing This Week
Motley Fool· 2 years agoWhat happened Shares of Novavax (NASDAQ: NVAX) were skyrocketing 28% higher this week as of the market close on Thursday, according to data provided by S&P Global Market Intelligence. On Tuesday ...
Novavax Stock Is Sizzling Hot Once Again -- Time to Buy?
Motley Fool· 2 years agoIt seems like a distant memory now, but Novavax (NASDAQ: NVAX) delivered a jaw-dropping 2,700% return in 2020. Between late September 2021 and mid-June 2022, Novavax's share price plunged by ...
3 Reasons to Buy Novavax and 1 to Sell
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) is a pandemic stock. Now it's down to $50, and the company's market cap is under $4 billion. Here are three arguments for buying...
